糖尿病手术患者术前高血糖的危险因素:一项病例对照研究。

IF 0.6 Q4 PHARMACOLOGY & PHARMACY
Peter Van Herk, Nathaniel Morin, Deonne Dersch-Mills, Rhonda Roedler, Beverly Ang, Lori Olivieri
{"title":"糖尿病手术患者术前高血糖的危险因素:一项病例对照研究。","authors":"Peter Van Herk,&nbsp;Nathaniel Morin,&nbsp;Deonne Dersch-Mills,&nbsp;Rhonda Roedler,&nbsp;Beverly Ang,&nbsp;Lori Olivieri","doi":"10.4212/cjhp.v75i1.3253","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with diabetes are more likely to undergo a surgical procedure than the rest of the population, and it is well established that preoperative hyperglycemia is associated with adverse surgical outcomes. However, it is currently unknown what factors increase the odds of preoperative hyperglycemia in people with diabetes.</p><p><strong>Objective: </strong>To identify patient characteristics that increase the risk of preoperative hyperglycemia.</p><p><strong>Methods: </strong>This retrospective case-control study compared 100 patients with preoperative hyperglycemia on admission for elective surgery at South Health Campus in Calgary, Alberta (blood glucose > 10.9 mmol/L) with 200 controls who did not have preoperative hyperglycemia on admission for elective surgery (blood glucose ≤ 10.9 mmol/L). Multivariate logistic regression was used to identify risk factors for preoperative hyperglycemia.</p><p><strong>Results: </strong>In the univariate analysis, age, number of comorbidities, increasing glycated hemoglobin (HbA<sub>1c</sub>), type of diabetes, type of procedure, and diabetes medications (non-insulin, insulin, both, or none) were associated with increased odds of preoperative hyperglycemia (<i>p</i> < 0.05). However, in the adjusted analysis, only increasing HbA<sub>1c</sub> (odds ratio [OR] 1.69, 95% confidence interval [CI] 1.36-2.12) and type 1 diabetes (OR 4.24, 95% CI 1.11-16.21, relative to type 2 diabetes) were associated with preoperative hyperglycemia.</p><p><strong>Conclusions: </strong>These results can help clinicians to identify patients who may be at increased risk of hyperglycemia before an elective procedure. They also allow for treatment of those who would benefit most from additional guidance with regard to preoperative glucose management.</p>","PeriodicalId":51646,"journal":{"name":"CANADIAN JOURNAL OF HOSPITAL PHARMACY","volume":"75 1","pages":"34-40"},"PeriodicalIF":0.6000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677004/pdf/cjhp-75-34.pdf","citationCount":"0","resultStr":"{\"title\":\"Risk Factors for Preoperative Hyperglycemia in Surgical Patients with Diabetes: A Case-Control Study.\",\"authors\":\"Peter Van Herk,&nbsp;Nathaniel Morin,&nbsp;Deonne Dersch-Mills,&nbsp;Rhonda Roedler,&nbsp;Beverly Ang,&nbsp;Lori Olivieri\",\"doi\":\"10.4212/cjhp.v75i1.3253\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Patients with diabetes are more likely to undergo a surgical procedure than the rest of the population, and it is well established that preoperative hyperglycemia is associated with adverse surgical outcomes. However, it is currently unknown what factors increase the odds of preoperative hyperglycemia in people with diabetes.</p><p><strong>Objective: </strong>To identify patient characteristics that increase the risk of preoperative hyperglycemia.</p><p><strong>Methods: </strong>This retrospective case-control study compared 100 patients with preoperative hyperglycemia on admission for elective surgery at South Health Campus in Calgary, Alberta (blood glucose > 10.9 mmol/L) with 200 controls who did not have preoperative hyperglycemia on admission for elective surgery (blood glucose ≤ 10.9 mmol/L). Multivariate logistic regression was used to identify risk factors for preoperative hyperglycemia.</p><p><strong>Results: </strong>In the univariate analysis, age, number of comorbidities, increasing glycated hemoglobin (HbA<sub>1c</sub>), type of diabetes, type of procedure, and diabetes medications (non-insulin, insulin, both, or none) were associated with increased odds of preoperative hyperglycemia (<i>p</i> < 0.05). However, in the adjusted analysis, only increasing HbA<sub>1c</sub> (odds ratio [OR] 1.69, 95% confidence interval [CI] 1.36-2.12) and type 1 diabetes (OR 4.24, 95% CI 1.11-16.21, relative to type 2 diabetes) were associated with preoperative hyperglycemia.</p><p><strong>Conclusions: </strong>These results can help clinicians to identify patients who may be at increased risk of hyperglycemia before an elective procedure. They also allow for treatment of those who would benefit most from additional guidance with regard to preoperative glucose management.</p>\",\"PeriodicalId\":51646,\"journal\":{\"name\":\"CANADIAN JOURNAL OF HOSPITAL PHARMACY\",\"volume\":\"75 1\",\"pages\":\"34-40\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677004/pdf/cjhp-75-34.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CANADIAN JOURNAL OF HOSPITAL PHARMACY\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4212/cjhp.v75i1.3253\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CANADIAN JOURNAL OF HOSPITAL PHARMACY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4212/cjhp.v75i1.3253","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:糖尿病患者比其他人群更容易接受外科手术,并且术前高血糖与不良手术结果相关已得到充分证实。然而,目前尚不清楚是什么因素增加了糖尿病患者术前高血糖的几率。目的:探讨增加术前高血糖风险的患者特征。方法:本回顾性病例对照研究比较了100例阿尔伯塔省卡尔加里南健康校区择期手术入院时术前高血糖患者(血糖> 10.9 mmol/L)和200例择期手术入院时无术前高血糖患者(血糖≤10.9 mmol/L)。采用多因素logistic回归分析术前高血糖的危险因素。结果:在单因素分析中,年龄、合并症数量、糖化血红蛋白(HbA1c)升高、糖尿病类型、手术类型和糖尿病药物(非胰岛素、胰岛素、两者都有或无)与术前高血糖发生率增加相关(p < 0.05)。然而,在调整后的分析中,只有HbA1c升高(比值比[OR] 1.69, 95%可信区间[CI] 1.36-2.12)和1型糖尿病(比值比[OR] 4.24, 95% CI 1.11-16.21,相对于2型糖尿病)与术前高血糖相关。结论:这些结果可以帮助临床医生在择期手术前确定高血糖风险增加的患者。它们还允许治疗那些最受益于术前血糖管理的额外指导的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Risk Factors for Preoperative Hyperglycemia in Surgical Patients with Diabetes: A Case-Control Study.

Background: Patients with diabetes are more likely to undergo a surgical procedure than the rest of the population, and it is well established that preoperative hyperglycemia is associated with adverse surgical outcomes. However, it is currently unknown what factors increase the odds of preoperative hyperglycemia in people with diabetes.

Objective: To identify patient characteristics that increase the risk of preoperative hyperglycemia.

Methods: This retrospective case-control study compared 100 patients with preoperative hyperglycemia on admission for elective surgery at South Health Campus in Calgary, Alberta (blood glucose > 10.9 mmol/L) with 200 controls who did not have preoperative hyperglycemia on admission for elective surgery (blood glucose ≤ 10.9 mmol/L). Multivariate logistic regression was used to identify risk factors for preoperative hyperglycemia.

Results: In the univariate analysis, age, number of comorbidities, increasing glycated hemoglobin (HbA1c), type of diabetes, type of procedure, and diabetes medications (non-insulin, insulin, both, or none) were associated with increased odds of preoperative hyperglycemia (p < 0.05). However, in the adjusted analysis, only increasing HbA1c (odds ratio [OR] 1.69, 95% confidence interval [CI] 1.36-2.12) and type 1 diabetes (OR 4.24, 95% CI 1.11-16.21, relative to type 2 diabetes) were associated with preoperative hyperglycemia.

Conclusions: These results can help clinicians to identify patients who may be at increased risk of hyperglycemia before an elective procedure. They also allow for treatment of those who would benefit most from additional guidance with regard to preoperative glucose management.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CANADIAN JOURNAL OF HOSPITAL PHARMACY
CANADIAN JOURNAL OF HOSPITAL PHARMACY PHARMACOLOGY & PHARMACY-
CiteScore
1.10
自引率
0.00%
发文量
64
期刊介绍: The CJHP is an academic journal that focuses on how pharmacists in hospitals and other collaborative health care settings optimize safe and effective drug use for patients in Canada and throughout the world. The aim of the CJHP is to be a respected international publication serving as a major venue for dissemination of information related to patient-centred pharmacy practice in hospitals and other collaborative health care settings in Canada and throughout the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信